Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity

References

Page 1

	Year	Citations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, CA A Cancer Journal for Clinicians	2021	109.5K
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, New England Journal of Medicine	2004	3.2K
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer Jacques Bernier, C. Domenge, Mahmut Özsahin, New England Journal of Medicine	2004	3.1K
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Jacques Bernier, Jay S. Cooper, Thomas F. Pajak, Head & Neck Surgical OncologyExtracapsular ExtensionSurgeryOnly Risk FactorsRadiation Medicine	2005	1.7K
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Karen K. Fu, Thomas F. Pajak, Andy Trotti, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineAccelerated FractionationRadiation TherapyFractionation RadiotherapyMedicine	2000	1.4K
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer K. Kian Ang, Andy Trotti, Adam S. Garden, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapySurgical OncologyTime FactorsRadiation TherapyAdvanced Head-and-neck Cancer	2001	625
Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck Jay S. Cooper, Qiang Zhang, Thomas F. Pajak, International Journal of Radiation OncologyBiologyPhysics Long-term Follow-upRadiation TherapyRtog 9501/IntergroupMedicinePhase Iii Trial	2012	589
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group Shanthi Marur, Shuli Li, Anthony J. Cmelak, Journal of Clinical Oncology	2017	486
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff, Clinical Cancer Research	2020	342
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial Journal of Clinical Oncology	2022	176

Page 1